Enzo Biochem Reviews

2.0
Recommend to a friend
Approve of CEO
Enzo Biochem Chairman and CEO Elazar Rabbani
Elazar Rabbani
1 Rating

Enzo Biochem Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.enzo.com
Headquarters New York, NY
Size 150 to 499 Employees
Founded 1976
Type Company - Public (ENZ)
Industry Health Care
Revenue $50 to $100 million (USD) per year
Competitors Unknown

For Enzo Biochem, antisense is perfectly sensible. The biotech company's Enzo Therapeutics segment develops antisense technology, a kind of gene therapy that switches off disease-causing genes, to fight such illnesses as HIV and Crohn's disease. Its work is funded by its two other segments: Enzo Clinical Labs which provides diagnostic testing services in the New York City area and Enzo Life Sciences which makes reagents used in research by pharmaceutical and biotech companies, as well as academic institutions. Enzo Biochem has collaborative partnerships with academic and... More

Work at Enzo Biochem? Share Your Experiences

Enzo Biochem

 
Click to Rate
or